Variable | Over all sample: n=694 | Female: n=234 | Male: n=460 |
---|---|---|---|
Age onset of Epilepsy: n (%) | |||
< 5years | 97 (14.00) | 33 (14.10) | 64 (13.90) |
5 – 14 | 167 (24.10) | 62 (26.50) | 105 (22.80) |
15 – 24 | 253 (36.50) | 74 (31.60) | 179 (38.90) |
25 – 34 | 99 (14.30) | 42 (17.90) | 57 (12.40) |
35 – 44 | 62 (8.90) | 20 (8.50) | 42 (9.10) |
>44 | 16 (2.30) | 3 (1.30) | 13 (9.10) |
Seizure experience | |||
Not controlled | |||
Severe | 270 (38.90) | 101(43.20) | 169 (36.70) |
Moderate | 72 (10.40) | 27 (11.50) | 45 (9.80) |
Mild | 169 (24.40) | 52 (22.20) | 117 (25.40) |
Controlled | 183 (26.40) | 54 (23.10) | 129 (28.00) |
Medication Regimens: n (%) | |||
Mono therapy | 541 (78.10) | 178 (76.10) | 363 (79.10) |
Poly therapy | 152 (21.90) | 56 (23.90) | 96 (20.90) |
Types of medication: n (%) | |||
Phenobarbitone | 557 (80.30) | 197 (84.20) | 360 (78.30) |
Carbamazepine | 128 (18.40) | 34 (14.50) | 94 (20.40) |
Phenytoin | 94 (13.50) | 33 (41.10) | 61 (13.30) |
Na-valporate | 53 (7.60) | 20 (8.50) | 33 (7.20) |
Co morbid illness: n (%) | |||
Yes | 170 (24.50) | 59 (25.20) | 111 (24.10) |
No | 524 (75.50) | 175 (74.80) | 349 (75.90) |
Medical co-morbidities: n (%) | |||
Hypertension | 43 (6.20) | 22 (9.40) | 21 (4.60) |
Diabetics | 36 (5.20) | 21 (9.00) | 15 (3.30) |
HIV | 41(5.90) | 30 (12.80) | 11 (2.40) |
Other | 9 (1.30) | 5 (2.10) | 4 (0.90) |
Psychiatric co-morbidities: n (%) | |||
Psychosis | 21 (3.00) | 9 (3.80) | 12 (2.60) |
Depression | 34 (4.90) | 17 (7.30) | 17 (7.30) |
Medication for co-morbid illness: n (%) | |||
Yes | 82 (11.80) | 41 (17.50) | 41 (8.90) |
No | 611 (88.00) | 193 (82.50) | 419 (91.00%) |
BMI: n (%) | |||
Under weight | 73 (10.50) | 32 (13.70) | 41 (8.90) |
Normal weight | 515 (74.20) | 156 (66.70) | 359 (78.00) |
Over weight | 106 (15.30) | 46 (19.70) | 60 (13.00) |